Does Semaglutide Cause Constipation?
Semaglutide, the active ingredient in drugs like Ozempic and Wegovy, lists constipation as a common gastrointestinal side effect. Clinical trials and FDA-approved labeling report it in 5-10% of patients, often mild and transient, linked to the drug's mechanism of slowing gastric emptying to promote satiety and weight loss.[1][2]
How Common Is Constipation on Semaglutide?
In STEP trials for weight loss (Wegovy), constipation occurred in 6-24% of participants on higher doses (2.4 mg weekly), dose-dependently, versus 1-6% on placebo. Pooled data from Ozempic trials show rates around 5-7%.[3][4] Real-world reports from patient forums and post-marketing surveillance align, though underreporting is possible.
Why Does Semaglutide Slow Digestion?
As a GLP-1 receptor agonist, semaglutide mimics gut hormones that delay stomach emptying and reduce intestinal motility. This curbs appetite but can harden stools and extend transit time, leading to constipation—especially early in treatment or with dose escalation.[5]
How Long Does Constipation Last?
Most cases resolve within 4-8 weeks as the body adjusts, but 1-2% experience persistent issues requiring intervention. Risk rises with dehydration, low-fiber diets, or concurrent opioids.[2][6]
What Helps Relieve Constipation?
- Increase water (2-3 liters daily) and fiber (25-30g from fruits, veggies, prunes).
- Add over-the-counter laxatives like polyethylene glycol (MiraLAX) or stool softeners; avoid stimulants long-term.
- Exercise regularly; prucalopride or lubiprostone for severe cases under medical advice.
Consult a doctor before changes, as severe symptoms may signal ileus.[1][7]
Compared to Other GLP-1 Drugs
| Drug | Constipation Rate | Notes |
|------|-------------------|-------|
| Semaglutide (Ozempic/Wegovy) | 5-24% | Highest at max dose |
| Tirzepatide (Mounjaro/Zepbound) | 6-13% | Similar, but more nausea |
| Liraglutide (Saxenda) | 10-20% | Shorter-acting, quicker onset |
| Dulaglutide (Trulicity) | 2-5% | Lowest reported |
Semaglutide's longer half-life prolongs effects.[3][8]
When to See a Doctor
Seek care for constipation lasting >1 week, with abdominal pain, vomiting, blood in stool, or unexplained weight loss beyond expected. Rare risks include bowel obstruction (0.1-0.4%).[2]
[1]: FDA Ozempic Label - https://www.accessdata.fda.gov/drugsatfdadocs/label/2023/209637s020lbl.pdf
[2]: FDA Wegovy Label - https://www.accessdata.fda.gov/drugsatfdadocs/label/2023/215256s007lbl.pdf
[3]: NEJM STEP 1 Trial (2021) - https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
[4]: Novo Nordisk Prescribing Info
[5]: Nature Reviews Endocrinology (GLP-1 Review, 2022)
[6]: Diabetes Care Journal (2023 Post-Marketing Analysis)
[7]: American Gastroenterological Association Guidelines
[8]: Lancet Tirzepatide vs Semaglutide Comparison (2023)